Directorate Change
14 June 2023
TruSpine Technologies plc
("TruSpine" or the "Company")
Directorate change
TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that the Company has terminated its letter of appointment agreement with Annabel Schild, Independent Non-Executive Director of the Company, with immediate effect and Ms. Schild has been removed as a director of the Company with immediate effect.
This announcement contains inside information for the purposes of the UK Market Abuse Regulation, and the Directors of the Company are responsible for the release of this announcement.
Enquiries:
|
TruSpine Technologies Plc |
Tel: +44 (0)20 7118 0852 |
|
Laurence Strauss, Chief Executive Officer |
|
|
|
|
|
Cairn Financial Advisers LLP (AQSE Corporate Adviser) |
Tel: +44 (0)20 7213 0880 |
|
Liam Murray / Ludovico Lazzaretti |
|
|
Oberon Capital (Joint Broker) |
|
|
Mike Seabrook / Chris Crawford
|
|
|
Peterhouse Capital Limited (Joint Broker & Financial Adviser) |
|
|
Lucy Williams / Duncan Vasey
|
|
|
Novus Communications (PR and IR) |
Tel: +44 (0)20 7448 9839 |
|
Alan Green / Jacqueline Briscoe |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 7 hours ago Legal & General Group
- 7 hours ago Legal & General Group
- 9 hours ago Mitie Group
- 10 hours ago Bezant Resources
- 10 hours ago Britvic